Treatments of the ALDH3A1‐expressing LUAD cell A549 and GBM cell SF767 with mafosfamide in combination with 10 μM CB7 enhance the antiproliferative effects over monotherapy.280. This evidence concerns the gene ALDH3A1 and glioblastoma.